ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NBRV Nabriva Therapeutics PLC

1.42
0.00 (0.00%)
Last Updated: 10:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.53M8.59M8.99M9.25M8.02M9.41M9.51M10.57M
Operating Income -13.45M-11.03M-10.68M-12.89M-11.56M-10.18M-10.85M-22.33M
Pre Tax Income -13.79M-11.15M-10.9M-13.12M-11.47M-10.69M-10.99M-22.47M
Net Income -13.98M-11.75M-10.65M-13.06M-11.82M-11.07M-11.51M-22.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -13.57M-10.91M-10.68M-12.89M-11.25M-10.18M-10.85M-22.33M
EBITDA -13.18M-10.83M-10.6M-12.81M-11.48M-10.11M-10.81M-22.31M
Year End 31 December 2022 20152016201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.77M6.54M5.81M9.66M9.7M6.21M29.36M37.51M
Operating Income -27.76M-54.99M-73.28M-114.65M-79.27M-64.94M-48.06M-54.92M
Pre Tax Income -47.41M-55.56M-73M-114.73M-82.66M-69.35M-48.96M-55.62M
Net Income -46.96M-54.89M-74.36M-114.78M-82.76M-69.48M-49.45M-57.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -22.195-20.18-2.026-1.713-0.875-3.296-0.872-17.865
EBIT -28.16M-54.99M-73.28M-114.65M-79.27M-67.7M-48.06M-54.92M
EBITDA -27.61M-54.76M-72.84M-114.14M-78.5M-64.12M-47.42M-54.7M

Your Recent History

Delayed Upgrade Clock